410 related articles for article (PubMed ID: 31774113)
1. An omics perspective on drug target discovery platforms.
Paananen J; Fortino V
Brief Bioinform; 2020 Dec; 21(6):1937-1953. PubMed ID: 31774113
[TBL] [Abstract][Full Text] [Related]
2. Network-based drug discovery by integrating systems biology and computational technologies.
Leung EL; Cao ZW; Jiang ZH; Zhou H; Liu L
Brief Bioinform; 2013 Jul; 14(4):491-505. PubMed ID: 22877768
[TBL] [Abstract][Full Text] [Related]
3. Target discovery from data mining approaches.
Yang Y; Adelstein SJ; Kassis AI
Drug Discov Today; 2009 Feb; 14(3-4):147-54. PubMed ID: 19135549
[TBL] [Abstract][Full Text] [Related]
4. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.
Cisek K; Krochmal M; Klein J; Mischak H
Nephrol Dial Transplant; 2016 Dec; 31(12):2003-2011. PubMed ID: 26487673
[TBL] [Abstract][Full Text] [Related]
5. Semantic data integration and knowledge management to represent biological network associations.
Losko S; Heumann K
Methods Mol Biol; 2009; 563():241-58. PubMed ID: 19597789
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Application of omics- and multi-omics-based techniques for natural product target discovery.
Zhang HW; Lv C; Zhang LJ; Guo X; Shen YW; Nagle DG; Zhou YD; Liu SH; Zhang WD; Luan X
Biomed Pharmacother; 2021 Sep; 141():111833. PubMed ID: 34175822
[TBL] [Abstract][Full Text] [Related]
8. Semantic Data Integration and Knowledge Management to Represent Biological Network Associations.
Losko S; Heumann K
Methods Mol Biol; 2017; 1613():403-423. PubMed ID: 28849570
[TBL] [Abstract][Full Text] [Related]
9. Integrating multiple 'omics' analysis for microbial biology: application and methodologies.
Zhang W; Li F; Nie L
Microbiology (Reading); 2010 Feb; 156(Pt 2):287-301. PubMed ID: 19910409
[TBL] [Abstract][Full Text] [Related]
10. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders.
Mensah GA; Yu W; Barfield WL; Clyne M; Engelgau MM; Khoury MJ
Genet Med; 2019 Mar; 21(3):519-524. PubMed ID: 30197419
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Approaches for Anti-cancer Drug Discovery.
Li K; Du Y; Li L; Wei DQ
Curr Drug Targets; 2020; 21(1):3-17. PubMed ID: 31549592
[TBL] [Abstract][Full Text] [Related]
12. Systems pharmacology: network analysis to identify multiscale mechanisms of drug action.
Zhao S; Iyengar R
Annu Rev Pharmacol Toxicol; 2012; 52():505-21. PubMed ID: 22235860
[TBL] [Abstract][Full Text] [Related]
13. Artificial Intelligence Approaches in Drug Discovery: Towards the Laboratory of the Future.
Frusciante L; Visibelli A; Geminiani M; Santucci A; Spiga O
Curr Top Med Chem; 2022; 22(26):2176-2189. PubMed ID: 36201265
[TBL] [Abstract][Full Text] [Related]
14. Real-time Data Fusion Platforms: The Need of Multi-dimensional Data-driven Research in Biomedical Informatics.
Raje S; Kite B; Ramanathan J; Payne P
Stud Health Technol Inform; 2015; 216():1107. PubMed ID: 26262406
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of Plant Productivity in the Post-Genomics Era.
Thao NP; Tran LS
Curr Genomics; 2016 Aug; 17(4):295-6. PubMed ID: 27499678
[TBL] [Abstract][Full Text] [Related]
16. Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery.
Jung HJ; Kwon HJ
Arch Pharm Res; 2015 Sep; 38(9):1627-41. PubMed ID: 26040984
[TBL] [Abstract][Full Text] [Related]
17. ORSO (Online Resource for Social Omics): A data-driven social network connecting scientists to genomics datasets.
Lavender CA; Shapiro AJ; Day FS; Fargo DC
PLoS Comput Biol; 2020 Jan; 16(1):e1007571. PubMed ID: 31978042
[TBL] [Abstract][Full Text] [Related]
18. Platforms for biomarker analysis using high-throughput approaches in genomics, transcriptomics, proteomics, metabolomics, and bioinformatics.
Merrick BA; London RE; Bushel PR; Grissom SF; Paules RS
IARC Sci Publ; 2011; (163):121-42. PubMed ID: 22997859
[TBL] [Abstract][Full Text] [Related]
19. Profiling disease-selective drug targets: From proteomics to ligandomics.
Waduge P; Tian H; Webster KA; Li W
Drug Discov Today; 2023 Mar; 28(3):103430. PubMed ID: 36343915
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
